Effect of meloxicam (cyclooygenase-2 inhibitor) versus vitamin D3 (cholecalciferol) as ameliorating agents of progressive doxorubicin-induced nephrotoxicity in rats

Doxorubicin (DOX)-induced nephropathy hampered its antineoplastic efficiency. The objective of the current work is to assess the prospective ameliorating effects of meloxicam versus vitamin D3 (Vit D3, cholecalciferol) against progressive DOX-induced nephropathy in rats trying to ascertain the possi...

Descripción completa

Detalles Bibliográficos
Autores principales: Elsherbini, Dalia Mahmoud Abdelmonem, Ebrahim, Hasnaa Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Anatomists 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343563/
https://www.ncbi.nlm.nih.gov/pubmed/32647085
http://dx.doi.org/10.5115/acb.19.231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343563/
https://www.ncbi.nlm.nih.gov/pubmed/32647085
http://dx.doi.org/10.5115/acb.19.231

Ejemplares similares